Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Reversible cerebral vasoconstriction syndrome following ciltacabtagene autoleucel therapy for relapsed multiple myeloma: a case report.
Journal: Frontiers in immunology
Published: January 07, 2026
Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies.
Journal: Blood cancer journal
Published: November 01, 2025
Genomic Determinants and Clinical Outcomes of Second Primary Hematological Malignancies in Patients with B-cell Cancers.
Journal: Transplantation and cellular therapy
Published: October 28, 2025
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era.
Journal: Haematologica
Published: February 07, 2025
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.
Journal: Journal of hematology & oncology
Published: December 24, 2024
Extensive Intracardiac Cement Embolism in a Patient Undergoing Workup for Bone Marrow Transplant.
Journal: Journal of hematology
Published: October 05, 2023
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma.
Journal: Blood cancer journal
Published: July 21, 2023
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.
Journal: Leukemia & lymphoma
Published: May 18, 2023
Last Updated: 09/26/2026